Package 55150-299-01

Brand: fosaprepitant dimeglumine

Generic: fosaprepitant dimeglumine
NDC Package

Package Facts

Identity

Package NDC 55150-299-01
Digits Only 5515029901
Product NDC 55150-299
Product ID 55150-299_37cc990f-95d3-42f3-8a13-aea0b1c7803b
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-299-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2021-01-12
Brand fosaprepitant dimeglumine
Generic fosaprepitant dimeglumine
Sample Package No

Linked Drug Pages (1)

FOSAPREPITANT DIMEGLUMINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "37cc990f-95d3-42f3-8a13-aea0b1c7803b", "openfda": {"unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["19919480-960b-4741-9611-c133d68512f5"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-299-01)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-299-01", "marketing_start_date": "20210112"}], "brand_name": "FOSAPREPITANT DIMEGLUMINE", "product_id": "55150-299_37cc990f-95d3-42f3-8a13-aea0b1c7803b", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "55150-299", "generic_name": "FOSAPREPITANT DIMEGLUMINE", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FOSAPREPITANT DIMEGLUMINE", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA210625", "marketing_category": "ANDA", "marketing_start_date": "20210112", "listing_expiration_date": "20261231"}